.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Nyce is stocked at 190 licensed dispensaries across New York, with the deepest coverage in New York, Buffalo, Queens, Rochester, and Depew. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Nyce’s category mix in July 2026 skewed toward Concentrates at 56.54% share with year-over-year growth of 67.93% but a month-over-month decline of 7.69%, while Edible climbed to 24.56% share with 236.71% year-over-year growth and a 8.19% month-over-month decline; Vapor Pens held 18.90% share with 36.72% year-over-year growth and a 11.24% month-over-month decline. Despite an overall brand sales increase of 82.53% year over year alongside an 18.16% drop in average price, the simultaneous month-over-month pullbacks across all three categories indicate price-led volume gains that are softening into July 2026, implying a pivot from rapid expansion to mix management as Edible’s surge rebalances a Concentrates-led portfolio.
With Concentrates still the plurality at 56.54% share and a state-category rank of 5 in New York, Nyce is positioned as a value-leaning extraction player whose reduced average price (-18.16% year over year) broadened access, while Edible’s 236.71% year-over-year growth reallocates demand into lower-priced, higher-velocity formats. The concurrent month-over-month declines in Concentrates (-7.69%), Edible (-8.19%), and Vapor Pens (-11.24%) suggest promotional elasticity is tapering and that sustaining rank 5 in Concentrates will require migrating some Edible-driven trial back into premium extraction SKUs, implying a strategy shift from discount-led acquisition to defending share in Concentrates while using Edible as a feeder for cross-category retention.
Competitive Landscape
Nyce sits at rank #5 in New York Concentrates for July 2026, up 4 positions year over year from #9 and 1 position ahead of April 2026’s #6, while its peak of #4 in February 2026 remains just out of reach; meanwhile, Mfny (Marijuana Farms New York) held steady at #1 with a 48.54% year-over-year sales increase and Jetpacks advanced from #3 to #2 on 56.77% growth, and UMAMII surged from #27 to #3 with 1,736.33% growth; paired with RYTHM holding #4 on 20.04% growth, this clustering above Nyce implies that sustaining a top-5 position will require outpacing multiple double- and quadruple-digit growers, and Nyce’s incremental climb suggests a ceiling risk without a step-change in velocity.
Notable Products
Papaya Mimosa Cold Cure Live Hash Rosin (1g) posted the steepest decline in July 2026 at -33.1% while sliding to rank 10, and Blueberry Sugar Free Live Hash Rosin Gummies 10-Pack (100mg) also contracted by -26.0% yet held rank 1; this divergence indicates price-insensitive pull at the very top alongside fragility in lower top-10 slots. Cherry Solventless Hash Rosin Gummies 10-Pack (100mg) advanced 32.3% to rank 2 while Peach Live Hash Rosin Gummies 10-Pack (100mg) fell -18.9% at rank 4, and five of the top ten are Edible SKUs, concentrating momentum in confections despite mixed month-over-month signals. GMO x Oreoz Cold Cure Live Hash Rosin (1g) dipped -10.7% at rank 9 versus Grape Solventless Hash Rosin Gummies 10-Pack (100mg) rising 23.6% at rank 3, and the single highest dollar volume among these top products reached $32,543, implying that concentrates still deliver ticket size even as relative growth tilts toward gummies. Taken together, the mix points to Nyce prioritizing scalable Edible throughput while selectively defending concentrate flagships, a shift that favors repeat purchase frequency over heavy-basket spikes.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
